INFLUENZA-B ANTIGEN
- UID
- MFG/MD/2020/000075_613f64c78c1f6f6ba32de6cd3d9eb39d_4a53e604481cd9f51dbac564446c50ad
- Device class
- Class C
- Brand name
- RECOMBIGEN
- License holder
- RECOMBIGEN LABORATORIES PVT. LTD
- Approving authority
- CDSCO -North Zone, Ghaziabad
- Product information
- The Influenza B Antigen Test is a rapid chromatographic immunoassay for the qualitative detection of Influenza B antigens in nasal swab specimens. It is intended to aid in the rapid diagnosis of influenza B viral infections.
INFLUENZA-B ANTIGEN is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2020/000075_613f64c78c1f6f6ba32de6cd3d9eb39d_4a53e604481cd9f51dbac564446c50ad. This device is marketed under the brand name RECOMBIGEN. The license holder is RECOMBIGEN LABORATORIES PVT. LTD, and it is classified as Device Class Class C. The approving authority is CDSCO -North Zone, Ghaziabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.